Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Genetic Heterogeneity of Residual Variance for Growth traits in American Angus Cattle

1 month 1 week ago
Economic incentives have increased the demand for uniformity in beef production, making it a valuable phenotype for genetic studies. Genetic heterogeneity of residual variance suggests that variability around the mean may have a genetic component and could potentially respond to selection. However, evidence for genetic control of residual variance in beef cattle remains limited. The objectives of this study were to 1) investigate genetic heterogeneity of residual variances for birth weight (BW),...
Sabrina T Amorim

American Radium Society (ARS) Appropriate Use Criteria (AUC) for Low-Dose Radiotherapy for Treatment of Osteoarthritis

1 month 1 week ago
CONCLUSIONS: This systematic review and consensus guidelines for LDRT treatment of OA are based on current evidence. Further high-quality studies are warranted.
Austin Dove

Prenatal Substance Exposure and Birth Weight: Findings From the HEALthy Brain and Child Development Study

1 month 1 week ago
CONCLUSIONS: In this initial HBCD Study data release, more than minimal exposure to cannabis and opioids was associated with smaller birth size, adding evidence to an inconsistent literature. Future studies from HBCD can more deeply interrogate timing and dose of each substance and expand to childhood outcomes.
Gretchen Bandoli

Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer

1 month 1 week ago
CONCLUSIONS: Our data indicates that 35% of the baseline submitted advanced technology IMRT plans required revision and resubmission in order to meet protocol standards. RT plan quality workflow continues to evolve with advanced techniques and has implications in clinical trial review. Pre- treatment plan review is an important quality measure for cervical cancer clinical trials.
Jyoti Mayadev

The silent epidemic: Cardiovascular mortality among patients with thyroid disorders-Insights from CDC-WONDER database (1999-2023)

1 month 1 week ago
Thyroid disorders substantially contribute to cardiovascular diseases (CVDs) in the United States. Although current U.S. data provides general mortality rates attributed to these diseases individually, trends specific to CVD-related mortality among patients with thyroid disorders remain underexplored. We examined the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database for deaths related to concomitant CVD and thyroid disorders among adults aged...
Maryam Saghir

Pagination

  • Previous page ‹ Previous
  • Page 147
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies